Showing 1 - 13 results of 13 for search 'D. Yu. Sedykh', query time: 0.02s Refine Results
  1. 1
    Remote active monitoring of patients after myocardial infarction: are there any advantages over standard outpatient monitoring?

    Remote active monitoring of patients after myocardial infarction: are there any advantages over standard outpatient monitoring? by D. Yu. Sedykh, T. S. Alkhimova, V. V. Kashtalap, O. L. Barbarash

    Published 2024-06-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Possibilities of PRECISE-DAPT Score for Risk Prediction of Ischemic and Hemorrhagic Events in ST-Elevated Myocardial Infarction (According to the Data of the Registry Study in Kemerovo)

    Possibilities of PRECISE-DAPT Score for Risk Prediction of Ischemic and Hemorrhagic Events in ST-Elevated Myocardial Infarction (According to the Data of the Registry Study in Keme... by D. Yu. Sedykh, V. V. Kashtalap, R. M. Velieva, O. L. Barbarash

    Published 2020-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Unresolved issues of increasing physical activity after myocardial infarction

    Unresolved issues of increasing physical activity after myocardial infarction by D. Yu. Sedykh, O. N. Khryachkova, K. E. Krivoshapova, D. P. Tsygankova

    Published 2022-06-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Predictors of ischemic and hemorrhagic complications in patients with myocardial infarction at 18-month follow-up: a single-center registry study

    Predictors of ischemic and hemorrhagic complications in patients with myocardial infarction at 18-month follow-up: a single-center registry study by V. V. Kashtalap, R. M. Velieva, D. Yu. Sedykh, O. L. Barbarash

    Published 2023-06-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Intensification of lipid-lowering therapy in very high-risk patients: potential of combination with PCSK9 inhibitors

    Intensification of lipid-lowering therapy in very high-risk patients: potential of combination with PCSK9 inhibitors by D. Yu. Sedykh, V. V. Kashtalap, O. N. Khryachkova, T. S. Petrova, O. L. Barbarash

    Published 2022-07-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Actual Issues of Ischemic and Hemorrhagic Events Risk Management During Antithrombotic Therapy in Patients with Acute Coronary Syndrome

    Actual Issues of Ischemic and Hemorrhagic Events Risk Management During Antithrombotic Therapy in Patients with Acute Coronary Syndrome by R. M. Velieva, T. B. Pecherina, A. S. Vorobiev, V. V. Kashtalap, D. Yu. Sedykh

    Published 2020-12-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Healthy nutrition in secondary prevention after myocardial infarction. What to focus on?

    Healthy nutrition in secondary prevention after myocardial infarction. What to focus on? by O. L. Barbarash, D. Yu. Sedykh, T. S. Petrova, V. V. Kashtalap, D. P. Tsygankova

    Published 2022-01-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Risk Factors, Clinical Features of the Course of Myocardial Infarction and Treatment of Young Patients Based on Two Hospital Registries

    Risk Factors, Clinical Features of the Course of Myocardial Infarction and Treatment of Young Patients Based on Two Hospital Registries by O. L. Barbarash, D. Yu. Sedykh, I. S. Bykova, V. V. Kashtalap, A. D. Erlich

    Published 2020-05-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Three Year Prognosis of Patients with Myocardial Infarction Depending on the Body Weight Index: Data of the Kemerovo Acute Coronary Syndrome Registry

    Three Year Prognosis of Patients with Myocardial Infarction Depending on the Body Weight Index: Data of the Kemerovo Acute Coronary Syndrome Registry by D. Yu. Sedykh, A. I. German, O. N. Hryachkova, V. V. Kashtalap, O. L. Barbarash

    Published 2022-03-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Clinical and biochemical markers of coronary artery calcification progression after elective coronary artery bypass grafting

    Clinical and biochemical markers of coronary artery calcification progression after elective coronary artery bypass grafting by O. L. Barbarash, D. Yu. Sedykh, V. V. Kashtalap, O. N. Hryachkova, A. N. Kokov, I. A. Shibanova

    Published 2022-01-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Possibilities of Combination of Beta-blockers and Ivabradine in Patients with Stable Angina Pectoris

    Possibilities of Combination of Beta-blockers and Ivabradine in Patients with Stable Angina Pectoris by V. V. Kashtalap, O. L. Barbarash, D. Yu. Sedykh, K. E. Krivoshapova, D. P. Tsygankova, O. V. Tsygankova

    Published 2019-11-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    PCSK9 inhibitors for in-hospital treatment of patients with acute coronary syndrome and severe lipid metabolism disorders

    PCSK9 inhibitors for in-hospital treatment of patients with acute coronary syndrome and severe lipid metabolism disorders by O. L. Barbarash, N. V. Fedorova, D. Yu. Sedykh, O. V. Gruzdeva, O. N. Khryachkova, V. V. Kashtalap, A. A. Filimonova

    Published 2020-09-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Molecular markers of cardiac fibrosis after myocardial infarction

    Molecular markers of cardiac fibrosis after myocardial infarction by O. L. Barbarash, A. G. Kutikhin, T. B. Pecherina, R. S. Tarasov, V. V. Kashtalap, N. V. Fedorova, L. A. Bogdanov, O. N. Hryachkova, D. Yu. Sedykh

    Published 2022-03-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: